Ikaros proteins are pleiotropic regulators of hematopoiesis and are critically required for the production of lymphocyte and dendritic cell (DC) lineages in mice. Here, we asked if Ikaros proteins could also play a role in the late stages of dendritic cell differentiation. Nuclear Ikaros proteins were up-regulated during the in vitro differentiation of human monocytes into mature DC, suggesting potential implications in this process. To address this question, a dominant negative mutant Ikaros isoform IK7 was over-expressed by retroviral gene transfer in human DC precursor cells, to interfere with the function of Ikaros family members during DC development. Expression of IK7 in CD34 + cells inhibited the production of IL-12-producing APCs. The resulting progeny of CD34 + cells and in particular, committed CD1a + DC or CD14 + cell-derived DC, expressed low levels of MHC class II antigens and of the CD83 maturation marker on the cell surface. Such IK7-expressing DC induced naõ Ève allogeneic T cells to produce Th2 cytokines. Our results therefore delineate a new role for Ikaros family members, showing that normal levels of Ikaros proteins are essential in DC to regulate the terminal stages of maturation and the capacity to induce optimal Th1 T cell responses.
Introduction
Dendritic cells (DC) constitute a complex system of antigen presenting cells (APC) with the paradoxical role of maintaining tolerance to self while inducing immune responses to foreign antigens (1) . Animal models or human cell systems have helped to understand the role of DC in immune regulation by identifying signals that control the development of immunostimulatory DC. Pathogens, in¯ammation or immune cells activate the migration of tissue-resident DC to local lymphoid organs and induce their functional maturation for effective presentation of antigens to T lymphocytes [reviewed by (2, 3) ]. A pivotal consequence of such process is the production of DC cytokines which is dynamically modulated by the environment, including reciprocal interactions with T cells via CD40/ CD40 ligand (CD40L) (4, 5) . The production of IL-12 by socalled type-1 DC leads to T cell responses with high levels of IFN-g and low levels of IL-4 or IL-10 (6). Maturation of DC also determines the outcome of antigen presentation by inducing high and speci®c levels of T cell-interacting molecules such as MHC and co-stimulatory antigens. The underlying molecular mechanisms engaged in DC that coordinate the features of activation remain incompletely characterized.
The study of DC transcription factors has provided valuable clues. NFkB becomes activated in murine and human DC after exposure to multiple pro-in¯ammatory signals including TNF-a and CD40L (7±9). Speci®c NFkB subunits, p50 and c-Rel, are required for the induction of IL-12 production and the survival of DC (10) . In contrast, RelB is critical for expression of CD40, CD86 and MHC class II on DC during maturation (11) . This suggests that a complex control of DC characteristics modulates T cell-mediated immune responses.
Speci®c transcriptional regulators, including NFkB constituents, also determine the existence of the various subsets of DC in murine lymphoid organs [(10,12) and some recently reviewed in (13) ]. In particular, Ikaros family members regulate DC lineages in vivo in mice (14) . Ikaros is the founding member of a family of Kru È ppel-type zinc ®nger transcriptional regulators comprising Ikaros, Aiolos, Helios, Eos and Pegasus (15±17) that control the development of the hemato-lymphoid system [reviewed in (18) ]. Multiple Ikaros isoforms exist that differ in the number of N-terminal zinc ®ngers enabling DNA binding. A mutant isoform lacking DNA-binding domains, IK7, can dimerize with other Ikaros isoforms or with family members via C-terminal interactions, thus functioning as a dominant negative regulator for this family of proteins (19) . Mice expressing the IK7 dominant negative mutation are de®cient in CD8a + and CD8a ± DC and Ikaros null animals lack CD8a ± DC in lymphoid organs, thus demonstrating the importance of these factors in the development of DC lineages (14) . Our own studies in human cells con®rm the importance of this family of proteins for DC formation. Hematopoietic progenitor cells (HPC) expressing IK7 fail to differentiate in vitro into CD1a + DC in response to speci®c cytokine signals (20) . Such study also delineated differential needs for Ikaros proteins in various systems of human DC hematopoiesis. Indeed, IK7 does not block the differentiation of HPC into CD1a + cells in response to GM-CSF, TNF-a and IL-4 cytokines, suggesting that the development of monocytic DC precursor cells, which respond to these cytokines (21), may be unaffected by IK7. Irrespective of effects on hematopoietic lineages, this system enables the production of human CD1a + DC in the presence of IK7, providing a model to analyze the functional characteristics of DC with impaired activation of Ikaros family members. It is not known if Ikaros proteins can, similarly to NFkB, regulate any of the functional attributes of DC maturation.
This led us to investigate in greater detail the role played by Ikaros proteins in the later stages of human DC development. Using retroviral transduction, we over-expressed IK7 into human HPC and analyzed production of immunostimulatory APCs in particular via monocytic precursor cells. We report that functional Ikaros proteins are not required for monocytederived DC formation but are required for the acquisition of optimal type 1 APC function.
Methods

Human cells
Human cell samples were obtained with approval from the Institutional Review Board of Wayne State University and included human umbilical cord blood (UCB) specimens, human adult bone marrow (BM) cells isolated from ribs removed during thoracic surgery and apheresed mobilized peripheral blood (MPB) of breast cancer patients. From these tissues, mononuclear cells (MNC) were prepared by centrifugation over Ficoll (Pharmacia, Piscataway, NJ). Monocytes were obtained by plastic adherence of MPB MNC and monocyte-derived DC (Mo-DC) were prepared as described (22) . BM or UCB CD34 + cells were puri®ed by positive selection using an indirect method and goat anti-mouse magnetic beads (Miltenyi Biotech GmBH, Sunnyvale, CA) as described (23) . Puri®ed UCB naive T cells were obtained after removal of monocytes, B cells, phagocytes, APC and erythrocytes using negative selection with sheep anti-mouse magnetic beads (Dynal) and mAbs speci®c for CD14 (3C10± 1E12), CD40 (G28.5), CD32 (IV-3), CD11b (OKM1), glycophorin A (10F7MN) (prepared from hybridomas obtained from ATCC, Manassas, VA), HLA-DP/DQ (SPVL-3) (kind gift of Dr H. Yssel) and CD16 (KD1) (kind gift of Dr G. Ferlazzo, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy) and mAbs to HLA-DR (Caltag, Burlingame, CA). Two consecutive rounds of negative selection were performed yielding >95% pure CD3 + naive T cells.
Retroviral production and transduction
The construction of the bi-cistronic vectors LZRS-IK7-IRES-EGFP and its control LZRS-IRES-EGFP encoding murine Ik7 and enhanced green¯uorescent protein (EGFP) or only EGFP have been reported elsewhere (20, 23) . Stable high-titer virusproducing Phoenix-amphotropic packaging cells (kind gift of Dr G. Nolan, Stanford University, Palo Alto, CA) were used to produce virus collected from con¯uent cell monolayers grown in R10 medium [RPMI-1640 medium (Gibco-BRL, Gaithersburg, MD) supplemented with L-glutamine (2 mM), penicillin±streptomycin (100U/ml and 100 mg/ml, respectively) and 10% fetal calf serum (Hyclone, logan, UT)]. Viruscontaining medium was ®ltered (0.45 mm) and stored frozen at ±80°C. Viral titers were determined by measuring EGFP expression after infection of HCT116 cells colon carcinoma cells. Virus batches of titer > 5 Q 10 5 U EGFP /ml were used.
Transduction of CD34 + cells (5 Q 10 5 cells/ml) was performed after 48 h pre-activation at 37°C in a humidi®ed atmosphere with 5% CO 2 in R10 medium supplemented with human recombinant c-kit ligand (50 ng/ml), interleukin-6 (25 ng/ml) and interleukin-3 (12.5 ng/ml). Cells were spininfected (24) at 1000 g for 3 h at room temperature with 1 ml of virus supernatant in the presence of 20 mM Hepes in 24-well plates coated with 8±11 mg/cm 2 ®bronectin fragments (Retronectin, Takara Biomedicals, Shiga, Japan). After centrifugation, cells were incubated overnight at 37°C with fresh virus supernatant in the presence of the above-described cytokines. The next day, cells were washed and further cultured with fresh medium and cytokines.
Cell sorting and culture of transduced cells
Live transduced cell subsets expressing EGFP and excluding propidium iodide (PI) (Sigma, St Louis, MO, 5 mg/ml) were obtained by¯ow cytometry sorting (Vantage sorter, Becton Dickinson, San Jose, CA). When indicated, cells were stained either for CD34, CD1a or CD14 using phycoerythrin (PE)-conjugated anti-CD34 mAbs, PE anti-CD1a, allophycocyanin or Tricolor-conjugated anti-CD14 mAbs (Caltag, Burlingame, CA). Sorted cells (5±10 Q 10 4 /ml) were cultured in 24-well plates (Corning Costar Corp, Oneonta, NY) in appropriate medium. Differentiation of CD34 + hematopoietic progenitor cells into monocytes and/or DC was induced by culture with different combinations of cytokines described elsewhere (5, 20) : FKGm17: Flt3 ligand, c-Kit ligand, GM-CSF (25 ng/ml each, kind gift of Dr B. Hill, SyStemix Inc or of Immunex, Seattle, WA), IL-7 and IL-1b (10 ng/ml each, R&D Systems, Minneapolis, MN) or FKGmT4: Flt3 ligand, c-Kit ligand, GM-CSF (25 ng/ml each), TNFa (50 ng/ml, RDI, Flanders, NJ or R&D Systems), and IL-4 (kind gift of Dr H. Yssel, DNAX, Palo Alto, CA) (100U/ml). Medium was changed by demi-depletion every 3 days.
Confocal microscopy
Cells spun on glass slides were air-dried and ®xed in cold methanol, thus eliminating EGFP¯uorescence of transduced cells. Cells were stained with FITC-conjugated anti-human HLA-DR (Caltag) and rabbit polyclonal anti-Ikaros antibodies [kind gift of Dr Katia Georgopoulos, Cutaneous Biology Research Center, Charlestown, MA, (19) ] revealed by Texas Red-conjugated goat anti-rabbit antibodies (Molecular Probes, Eugene, OR). Negative controls consisted of cells stained with FITC-conjugated irrelevant mouse IgG, preimmune rabbit serum and anti-rabbit conjugate. Cells were examined by confocal microscopy (Zeiss LSM 310) using a 488 nm Argon laser and a 63Q objective.
Cell surface marker analysis by¯ow cytometry
Non-speci®c binding was blocked with human g-globin (Gamimune, Miles, Eckhart, IN) for 10 min followed by addition of mAbs such as: PE anti-CD1a, anti-CD54, anti-CD11c, anti-CD4 (Caltag), PE anti-CD83 (Caltag or PharMingen, San Diego, CA), PE-anti CD80 (Pharmingen), allophycocyanin anti-CD14 and allophycocyanin anti-MHC class II (Caltag). In some experiments, indirect stainings were also used to detect CD80, CD86 (Pharmingen), CD40 (G28.5) or MHC class I (W6/ 32) antigens using PE-conjugated goat anti-mouse Ig (Chemicon, Temecula, CA). Negative controls included IgG1 and IgG2a irrelevant mAbs. Data were acquired using a FacsCalibur instrument (Becton Dickinson) and analyzed with WinMDI software, version 2.8 (The Scripps Research Institute, La Jolla, CA).
MLR
Mixed lymphocyte reactions (MLR) were initiated by incubating allogeneic naive UCB T cells and APCs in R10 for 5±10 days. At indicated times, culture medium was collected and stored frozen at ±20°C prior to analyzing cytokine content by ELISA with OPTEIA human INFg Kit, OPTEIA human IL-10 Kit (PharMingen, San Diego, CA) and IL-4 ELISA kit (R&D Systems) according to the manufacturer's instructions. To measure T cell proliferation, APCs were irradiated (3000 cGy from a 131 Cs source, JL Sheperd, San Fernando, CA), washed and added at various concentrations to 5 Q 10 4 allogenic UCB T cells in 96-well U-bottom tissue culture plates (0.2 ml of R10 medium per well). Proliferation was measured after adding 1 mCi of 3 H thymidine (DuPont NEN, Boston, MA) per well during the last 12 h of culture. Results were expressed as stimulation indices (SI) = average counts per minute of triplicate wells in test culture/average counts per minute of triplicate wells of T cells alone.
IL-12 p70 production
Cells were cultured with human recombinant CD40-ligand (1 mg/ml, kind gift of Immunex) in R10 medium for 24 h. Supernatant¯uids were collected to measure IL-12 secretion by ELISA using the OPTEIA human IL-12 (p70) Kit (PharMingen, San Diego, CA according to the manufacturer's instructions).
Results
Expression of Ikaros proteins in Mo-DC
Little is known of the expression of any Ikaros family member in human DC or their precursor cells. Using immuno¯uorescence and confocal microscopy we observed that Ikaros levels were below detection in human adherent blood monocytes ( Fig. 1 ; day 0). However differentiation into Mo-DC was accompanied by induction of high levels of Ikaros in the form of speckles in the nucleus. Levels peaked between days 4 and 7 of culture, coinciding with optimal differentiation of Mo-DC (25) . Levels of Ikaros subsequently declined in intensity but persisted for 2 weeks (Fig. 1) . Thus, Ikaros proteins are present in Mo-DC and are up-regulated during their differentiation/maturation. Possibly, Ikaros proteins may play a role in this process.
Expression of DN IK7 in CD34 + cells reduces the production of mature DC To evaluate the importance of Ikaros proteins in the production of functional DC, we expressed the dominant negative mutant IK7 by retroviral-mediated gene transfer into multipotential HPC as described previously (20) . Transduced EGFP + CD34 + Fig. 1 . Ikaros protein expression in Mo-DC. Adherent blood monocytes (day 0) were cultured with FKGmT4 cytokines and cells were sampled at different times of culture, spun on slides and ®xed in cold methanol. All samples were stained for Ikaros protein expression using indirect immuno¯uorescence and analyzed simultaneously by confocal microscopy. cells were puri®ed by¯ow cytometry then subsequently cultured in the presence of cytokines¯t-3-ligand, c-kit ligand, GM-CSF, TNF-a and IL-4 (FKGmT4) to induce DC differentiation and maturation as previously reported (5, 20, 25) . Within a week, CD1a + CD14 ± DC represented 23±69% of the cells in control cultures and 10±55% of cells in IK7 cultures (Table 1) . Cells with typical dendritic morphology were seen in both cultures. Thus, we con®rm that IK7 did not prevent the differentiation of CD34 + cells into CD1a + cells in response to FKGmT4 cytokines (20) , and extend these observations to show that CD1a + CD14 ± DC expressing IK7 can be produced in this system. HPC-derived CD1a + CD14 ± DC mature over time due to the presence of TNF-a in the culture medium, and express CD83, CD80, CD86, CD11c and HLA-DR antigens (25) . In contrast, HPC expressing IK7 generated fewer cells expressing HLA-DR, CD83 and CD80 or CD11c (Table 1 ; whole cultures). Figure 2 illustrates a representative experiment. IK7 reduced intensity of HLA-DR, CD83, CD40, CD11c, CD80 and CD86 while CD1a was found on a large majority of the cells, not differently from control cultures. To facilitate the analysis of multiple markers on transduced DC, we puri®ed EGFP + CD1a + CD14 ± DC by¯ow cytometry and after a short culture, cells were immunostained again (Table 1 ; puri®ed DC). IK7 did not modify expression of CD80, CD86 or CD40, but the reduced expression of CD83 and HLA-DR was con®rmed. This indicates that IK7 perturbed the production of mature DC from HPC and speci®cally affected the expression of HLA-DR and CD83 on the committed CD1a + CD14 ± DC subset.
Expression of DN IK7 reduces the generation of type-1 DC activity
Type-1 DC can be produced in vitro by culture of human CD34 + HPC (21), notably in the presence of FKGmT4 C  IK7  C  IK7  C  IK7  C  IK7  C  IK7  C  IK7  C  IK7  C  IK7   Whole cultures a  1  45  27  59  38  98  92  59  61  12  4  19  2  75  52  23  4  2  23  10  66  49  80  85  30  30  10  6  11  3  47  30  11  3  3  69  55  84  77  92  81  69  58 cytokines as we reported (5, 25) . Indeed, activation of control HPC-derived cells with soluble trimeric CD40L induced the secretion of IL-12ab in medium (Fig. 3) . In contrast, IK7-expressing HPC-derived cultures secreted signi®cantly less IL-12 (P = 0.003, t-test). T cell-activating properties of these APCs were analyzed in MLR. Control cells induced the proliferation (Fig. 4) and the production of IFN-g by naive allogeneic T cells (Table 2) . Cells expressing IK7 also induced T cell proliferation, although a statistically-signi®cant reduction (P < 0.01, t-test) was observed at the highest ratio of DC to T cell tested, but this was not apparent at other ratios. However, IK7-expressing APCs induced abnormal cytokine differentiation of T cells with lower production of IFN-g and higher levels of IL-4 than controls (Table 2; experiments 1 and 2) . Altogether, results demonstrate that IK7 expression reduced the production of mature, functional type-1 DC from HPC.
To better understand the effects of IK7 irrespective of possible effects on hematopoiesis, we puri®ed CD1a + CD14 ± DC from HPC-derived cultures. In MLR, such IK7 + CD1a + CD14 ± DC consistently induced T cells to produce higher levels of IL-4 than control DC (Table 2 ; experiments 3±6). In contrast, the production of IFN-g was variable but overall not signi®cantly modi®ed from controls. Thus, IK7 expression in committed DC impaired antigen presenting cell function, reducing HLA-DR and CD83 expression and resulting in higher levels of IL-4 production by T cells.
IK7 does not prevent the formation of monocytes and Mo-DC
Next, we wanted to speci®cally examine the production and function of CD1a + DC derived from monocytes as these are well-de®ned type-1 DC (26) . First, we asked if this pathway of DC formation was affected by IK7. To generate Mo-DC from HPC, we established two-step cultures. First, HPC were cultured with the cytokines¯t-3-ligand, c-kit ligand, GM-CSF, IL-1b and IL-7 (FKGm17) to generate CD14 + cells (20) . As seen in Fig. 5A (top panels), CD14 + cells were abundantly produced in control and IK7 cultures with no statistically signi®cant difference in numbers of CD14 + cells produced (n = 5, data not shown). Subsequently, we added TNF-a and IL-4 to the cultures for 5 days to induce the differentiation and maturation of monocytic DC precursor cells into DC. Irrespective of IK7, this generated high proportions of CD1a + CD14 ± DC (Fig. 5A , bottom panels, n = 2). Thus, IK7 did not prevent the production of monocytes from HPC and their subsequent differentiation into Mo-DC.
IK7 affects T cell-stimulating ability of Mo-DC
Functional properties of Mo-DC obtained in two-step cultures were examined. In these experiments an additional control was included, consisting of cells exposed to the IK7 vector but failing to become infected. Such EGFP negative cells (IK7-neg cells) had a similar cell surface phenotype to controltransduced cells, displaying high levels of HLA-DR, CD83, CD11c, CD54 and CD80 (Fig. 5B and C) . In contrast, IK7 + Mo- Cells were produced as in Table 1 . Responder cells consisted of cord blood puri®ed T cells. MLR was set at a ratio of 1 stimulator per 10 responder cell. Cytokines were measured in the MLR culture medium after 7±8 days. Mo-DC produce IL-12 in response to CD40L and the levels are regulated by temporal and maturation effects. IL-12 production capacity is highest in immature Mo-DC compared to DC previously matured with TNF-a (27±29). The effects of IK7 were therefore tested in these two distinct stages of maturation. Immature DC were produced in two step cultures, respectively omitting or including the maturation agent TNF-a. Two experiments showed that IK7 did not signi®cantly affect the production of CD40L-induced IL-12 by puri®ed Mo-DC either in the immature or TNF-matured state (Fig. 6) . Thus, IK7 caused abnormal phenotype in Mo-DC with reduced levels of HLA-DR and CD83 but IL-12 production seems unaffected in these cells.
Discussion
In this study, we show that IK7 affects the phenotype and T cell-activating properties of committed DC. This demonstrates that normal levels of Ikaros proteins are required to control the late functional stages of DC development in addition to a previously recognized role in DC hematopoiesis (20) .
We ®nd that Ikaros family members play a role in committed DC produced in various systems of culture. A consistent effect of IK7 was the reduction of HLA-DR and CD83 on CD1a + CD14 ± DC and Mo-DC. We also show that IK7 + DC derived from HPC reproducibly induced Th2 cytokines in T cells. Preliminary experiments seem to con®rm these observations in Mo-DC because immature IK7 + Mo-DC induced higher levels of IL-4 and IL-10 in secondary MLR compared to control Mo-DC (data not shown). Th2 T cell development is known to be induced by low doses of antigen (30±35). Being MHC class II low APCs, IK7 + DC would therefore present low amounts of antigen in MLR and thus could induce Th2 development through this mechanism. In uncharacteristic fashion, IK7 + DC concomitantly induced IFN-g with Th2 cytokines. This is probably due to their ability to produce IL-12 which is a dominant signal for the instruction of Th1 T cell differentiation (6, 36) . Thus, reduced HLA-DR expression with capacity to produce IL-12 is most likely responsible for the unusual coinduction of IFN-g and IL-4 by IK7 + DC. An interesting result is that IK7 profoundly affected the immune functions of APCs obtained in whole cultures. Contrary to puri®ed DC, IK7 reduced not only HLA-DR and CD83 but also accessory and co-stimulatory molecules CD54, CD40, CD80, CD86 on the whole APC population. Hindering ICAM-1/LFA-1, CD40/ CD154, CD80/CD28 interactions is expected to impair APC/ T cell interactions and to bias the response towards Th2 T cell responses. Contrary to puri®ed DC, IK7 also markedly reduced the capacity of the whole APC population to produce IL-12 which is expected to further impair Th1-inducing capacity (28) . Indeed, we observed that whole APCs expressing IK7 induced less IFN-g and more IL-4 than control APCs. Intracellular T cell cytokine contents analyzed in one experiment, con®rmed this trend and also showed the induction of distinct subsets of IFN-g and IL-4-producing T cells, suggesting that IK7-expressing APCs impaired Th1 responses while inducing Th2 T cell differentiation (data not shown). The observed phenotypic anomalies of IK7 + APCs may explain these ®ndings but we cannot exclude that additional perturbations were also induced by IK7 including non-autonomous effects or generation of a distinct subset of APCs with speci®c Th2-inducing capacity. Since IK7 inhibited more IL-12 production in whole cultures than in puri®ed DC, it is possible that IL-12-producing cells other than CD1a + DC could be severely affected by IK7. Such cells were not studied here. We have recently shown that IL-12 production by human DC was critically dependent upon NFkB p50 (37) . Preliminary results showed that IK7 reduced p50 expression in the HPC-derived cell population (data not shown) which is consistent with the observed effect on IL-12. This evokes complex interplays between the effectors of various signaling pathways in DC.
Our results also highlight that features of DC maturation, such as expression of HLA-DR and CD83, can be regulated independently of others. Mechanisms by which IK7 affects HLA-DR or CD83 are not known. We detected little intracellular HLA-DR in IK7-expressing cells (data not shown) excluding in principle an effect on retention of vesicular MHC class II complexes as found in immature DC. It is theoretically possible that Ikaros proteins regulate the transcription of MHC class II and CD83. Constitutive or inducible transcription of MHC Class II is regulated by RFX complex proteins that bind to class II promoter regions and recruit the MHC Class II transactivator CIITA (38) . Ikaros core consensus binding sites (GGGAA) (39) were found in the 3¢ UTR of RFX-AP, in the 5¢ and 3¢ UTR of RFX-associated ankyrin containing protein, in the RFX2 and HLA-DR genes and more sparsely in the CIITA gene (A. Galy, unpublished observations) supporting this hypothesis. In addition, ®ve core consensus binding sites were identi®ed in the CD83 promoter (A. Galy, unpublished observations). Such speculations require testing in a separate study.
Thus, molecular mechanisms engaged during the process of DC activation are multifaceted and involve in part, Ikaros family members. At present it is not possible to implicate any speci®c member because the experimental system was nondiscriminative, since IK7 associates and perturbs the activity of multiple partners within the family (19) . Candidates include Ikaros itself which we ®nd expressed in Mo-DC. We also detected Aiolos mRNA in Mo-DC and CD34 + -derived DC (A. Galy, unpublished observations). Murine DC reportedly express Ikaros and Helios mRNA preferentially in splenic CD8a + DC and in thymic DC whereas Aiolos is preferentially detected in splenic CD8a ± DC (15) . The existence of multiple family members and the fact that DC development is more severely impaired in Ikaros DN mice than in Ikaros null mice (14) suggests that various aspects of DC formation, activation and maturation may require different Ikaros family members. Our results extend developmental studies in animals at several levels. In part, we ®nd that normal activity of Ikaros proteins is not critical for the formation of human Mo-DC in vitro. Thus, speci®c DC precursor cells or speci®c signaling pathways in DC may be independent of Ikaros protein-mediated functions. By extrapolation to the murine system, this may explain why some populations of DC persist in the skin of DN mice while those in lymphoid organs are affected (14) .
For the ®rst time, Ikaros family members can be implicated in the functional activation of DC. Our data therefore provide a previously unrecognized element in the regulation of antigen presentation that should be considered in the signaling cascade involved in DC activation.
